Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study

Suchita Pakkala, Taofeek K. Owonikoko, Zhengjia Chen et al.|Journal for ImmunoTherapy of Cancer|2020

Cited by 67